62559-08-4

Upstream product

• 98-51-1 4-tert-butyltoluene 
• 7664-93-9 sulfuric acid 
• 7697-37-2 nitric acid 

Downstream Products

• 103797-19-9 4-(tert-butyl)-2-nitrobenzoic acid 
• 85336-17-0 5-tert-butyl-2-methylaniline 
• 96864-00-5 4-(1,1-dimethylethyl)-2-nitrobenzaldehyde 
• 134541-50-7 1-bromomethyl-4-tert-butyl-2-nitrobenzene 
• 261712-27-0 3-(4-tert-butyl-2-nitro-phenyl)-2-oxo-propionic acid ethyl ester 
• 85336-18-1 N-acetyl-5-tert-butyl-2-methylaniline 
• 239804-62-7 (5-tert-Butyl-4-mercapto-2-methyl-phenyl)-carbamic acid tert-butyl ester 
• 239804-61-6 Boc-protected 3-tert-butyl-6-methyl-4-thiocyanatoaniline 
• 207737-29-9 toluene-4-thiosulfonic acid S-(4-amino-2-tert-butyl-5-methylphenyl) ester 
• 625447-26-9 toluene-4-thiosulfonic acid S-(4-acetylamino-2-tert-butyl-5-methyl-phenyl) ester 
• 239804-63-8 Toluene-4-thiosulfonic acid S-(4-tert-butoxycarbonylamino-2-tert-butyl-5-methylphenyl) ester 

Relevant academic research and scientific papers

METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL

The present invention relates to: a method for converting a hydroxyl group of an alcohol; and a catalyst which makes the method possible. A method for converting a hydroxyl group of an alcohol according to the present invention is characterized by producing a compound represented by CH(R1)(R2)Nu (wherein R1, R2 and Nu are as defined below) by reacting an alcohol represented by CH(R1)(R2)OH (wherein each of R1 and R2 represents a hydrogen atom, an optionally substituted alkyl group, or the like) and a compound having an active proton, which is represented by H-Nu (wherein Nu represents a group represented by —CHX1-EWG1 or —NR3R4; X1 represents a hydrogen atom or the like; EWG1 represents an electron-withdrawing group; and each of R3 and R4 represents a hydrogen atom, an optionally substituted alkyl group, or the like), with each other in the presence of a complex of a group 7-11 metal of the periodic table and at least one solid base that is selected from the group consisting of layered double hydroxides, composite oxides and calcium hydroxide.

Modulation of Electronic Mobility of a One-Dimensional Coordination Polymeric Molecular Wire with Light

Metal ions often influence the photoswitching efficiency of a photochromic system. This article reports a one-dimensional polymer having cyclic azobenzenes coordinated to silver ions that are bridged by nitrates. The coordination polymer (CP-2) displays a

DUAL AGONISTS OF FXR AND PPARδ AND THEIR USES

The present invention relates to small molecule compounds and their use as agonists of farnesoid X receptor (FXR) and/or peroxisome proliferator activated receptor delta (PPARδ). The present invention also relates to the use of said compounds in the treatment of metabolic diseases and respective methods of treatment.

Strain, switching and fluorescence behavior of a nine-membered cyclic azobenzene

Cyclic azobenzenes with ring strain possess improved photochromic properties in comparison to their acyclic analogs. In this study, we report a nine-membered cyclic azobenzene. This cyclic azobenzene follows the stability of the acyclic systems with the t

Meta-Oligoazobiphenyls - Synthesis via site-selective Mills reaction and photochemical properties

The investigation of multi-photochromic compounds constitutes a great challenge, not only from a synthetic point of view, but also with respect to the analysis of the photochemical properties. In this context we designed a novel strategy to access meta-ol

Brightly shining nanoparticles: Lipophilic perylene bisimides in aqueous phase

The dispersion of lipophilic perylene bisimides down to nanoparticle dimensions opens the aqueous phase to these highly fluorescent, water insoluble materials. The Royal Society of Chemistry and the Centre National de la Recherche Scientifique.

Metal complexes of tetra(6-tert-butyl-2,3-quinolino)porphyrazine: I. Synthesis

Complexes of tetra(6-tert-butyl-2,3-quinolino)porphyrazine with Cu, Co, Zn, and Ni soluble in hydrophobic liquids were synthesized for the first time by template tetramerization of derivatives of 6-tert-butylquinoline-2,3- dicarboxylic acid formed from the corresponding acid in the course of carbamide synthesis in presence of the bivalent metal ions.

AMINOQUINAZOLINE CANNABINOID RECEPTOR MODULATORS FOR TREATMENT OF DISEASE

The present invention relates to compounds and methods useful as modulators of CB2 for the treatment or prevention of disease states including, but not limited to pain, autoimmune disease, malabsorption syndrome, pulmonary disease, osteoporosis, muscle spasm in cancer, neuromuscular disorder, and atherosclerosis progression.

HETEROCYCLIC NON-PEPTIDE GNRH ANTAGONISTS

A compound of formula (I): wherein either B is absent and A and Z are the same or different and are each hydrogen, halogen, alkyl, hydroxy, alkoxy,-CN,-C(Rc)2OH,-N(Rd)C(=X)Rc,-C(=X)N(Rc)(Rd),-S(O)m-Rc,-N(Rc)(Rd)S(O)2,-S(O)2N(R c)(Rd),-N(Re)2, aryl optionally substituted with Ra or-O-aryl optionally substituted with Ra; or B is present and is-(CH2)n-,-C(Rb)2-or-O-, or B taken together with A or Z can be-C=C(Rb)-,-C(Rb)=C-,-CH2-CH(R b)-or-CH(Rb)-CH2-; D is-O-or-S(O) m,-; E is a bond or is-(CH2)n-,-N(R d)-,-(CH2)nN(Rd)-or-N(R d)(CH2)n-; F is-C(=X)-; G is-(CH2 )n-,-N(Rd)-,-(CH2)nN(R d)-or-N(Rd)(CH2)n; J is a bond,-O-,-N(RC)C(=X)-,-C(=X)N(Rc)-,-S(O)m,-,-N(Rc)S(O)m-,-S(O)nN(Rc)-,-N(Re)-or-N(Rg)(Rh); K is a bond, alkylene, cycloalkylene, cycloalkenylene, arylene, heterocycloalkylene, heterocycloalkylene or heteroarylene; and L is hydrogen or a terminal group; has therapeutic utility.

QUINAZOLINONES

Disclosed are compounds of formula (I), wherein R, R1, R2, R3, R4, R5, R6, R7, R8, Z1, Z2, Z3, k, and Y1 have the meanings indicated in claim 1. Said compounds can be used for the treatment of tumors, among other things.